Our eleventh episode of the Life Sciences Connect series explores the critical role AI plays in Biopharma launch and commercial activities.
This month’s podcast explores one of our latest reports - Intelligent drug launch and commercial: Optimising value through AI.
We discuss the potential of Artificial intelligence to radically change the Biopharma commercial model, helping companies improve both drug launches and their commercial models. We reflect on the areas where companies are successfully adopting AI, the challenges of upscaling AI solutions and the key organisational, people, process and technological changes required to support an AI-driven commercial model.
If you are interested in any of the topics discussed during this episode, please find useful links below:
To see the full collections of episodes so far, please visit the Life Sciences Connect podcast library.